Alexandra Gardino

Alexandra Gardino has worked in a variety of positions in the pharmaceutical industry. Alexandra began their career in 1999 as a Graduate Student at Brandeis University. In 2000, they took on a summer intern role at AstraZeneca R&D. From 2005 to 2011, they were a Postdoctoral Fellow at MIT. Following this, they worked as a Senior Scientist at Blueprint Medicines from 2011 to 2018. Since 2018, they have been a Director at Accent Therapeutics, Inc. and is currently a Director at Recludix Pharma.

Alexandra Gardino received their B.S. in Molecular Biology and Biochemistry from Rutgers University between 1995-1999. Afterwards, they attended Brandeis University and obtained their Ph.D. in Biophysics and Structural Biology between 1999-2005.